"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Comment from Serrao et al.
Alessandra SerraoGiovanni Manfredi AssantoFrancesco MalfonaGabriela Chavez OrellanaAntonio ChistoliniPublished in: Journal of thrombosis and haemostasis : JTH (2022)